Imprivata Inc.

https://www.imprivata.com/

Imprivata is a digital identity security company specializing in access management and authentication solutions. Headquartered in Waltham, Massachusetts, the company's mission is to deliver simple and secure access for mission-critical industries, ensuring frictionless and secure workflows.

Imprivata offers a platform of interoperable solutions including Single Sign-On (SSO), Multifactor Authentication (MFA), Mobile Access Management, User Behavior and Access Analytics, Privileged Access Management (PAM), Third-Party Access Control, Remote Support, and Identity Threat Detection and Response. Key products include Imprivata OneSign for SSO and Imprivata Confirm ID for MFA. While primarily serving the healthcare industry, Imprivata also caters to other highly regulated sectors such as manufacturing, state and local government, financial services, gaming, and transportation.

Fran Rosch assumed the role of CEO on January 1, 2024, bringing extensive experience in enterprise security and identity management. Recent developments include the introduction of Agentic Identity Management for AI agents, integration with Netskope for Zero Trust Security, and the launch of Imprivata Patient Access in Epic Toolbox for identity verification in early 2026. In May 2024, Imprivata released Enterprise Access Management Analytics to provide deeper insights into user access workflows. The company, which was acquired by private equity firm Thoma Bravo in 2016, is reportedly being considered for sale by its parent company for an estimated $7 billion as of February 2026.

Latest updates

Imprivata Taps KnowBe4's Zhou to Drive Access Management Growth

Event summary

  • Cindy Zhou has been appointed Chief Marketing Officer (CMO) of Imprivata, effective immediately.
  • Zhou previously served as CMO at KnowBe4, where she oversaw the company's growth to over 70,000 global customers.
  • Zhou's prior experience includes leadership roles at LogRhythm (now Exabeam), IBM, and Verizon.
  • She holds an MBA from Louisiana State University and a BA from the University of Maryland.

The big picture

Imprivata's appointment of Cindy Zhou signals an intent to aggressively pursue market share in the increasingly complex digital identity and access management landscape. The company's focus on frictionless, secure access aligns with broader trends toward zero-trust architectures and the growing regulatory pressure on data security, particularly within the healthcare sector. Zhou’s experience scaling KnowBe4 suggests a focus on rapid expansion and potentially a shift towards a more sales-driven marketing approach.

What we're watching

Growth Strategy
Zhou's focus on accelerating growth will be critical given Imprivata's position in a competitive market; her track record at KnowBe4 will be scrutinized for applicability to Imprivata's existing product suite and target verticals.
AI Integration
The stated emphasis on 'agentic AI governance' suggests Imprivata intends to aggressively integrate AI into its access management platform, which carries both opportunity and execution risk.
Brand Positioning
With Zhou's experience on the WSJ CMO Council, expect a shift in Imprivata’s brand messaging and a greater emphasis on thought leadership within the cybersecurity space, potentially impacting its competitive positioning.

Imprivata Bolsters NHS Access Management with Passwordless Authentication

Event summary

  • Imprivata released new features for its Enterprise Access Management (EAM) platform on March 17, 2026.
  • The update focuses on advanced access management and passwordless authentication tailored for UK healthcare providers, specifically addressing compliance requirements like the Cyber Assessment Framework (CAF)-aligned Data Security and Protection Toolkit (DSPT) and NHS England Spine Authentication.
  • New features include context-aware passwordless authentication, AI-powered behavioral analytics, and role-based access controls.
  • Imprivata will demonstrate the new functionality at Digital Health Rewired 2026 in Birmingham on March 24-25.

The big picture

The UK’s National Health Service (NHS) is facing mounting pressure to modernize its IT infrastructure while adhering to increasingly complex cybersecurity and compliance mandates. Imprivata’s move to integrate advanced access management and passwordless authentication directly addresses this need, positioning the company to capitalize on a growing market for secure and efficient healthcare technology solutions. This expansion is likely a response to broader trends of Zero Trust architecture adoption and the increasing prevalence of remote work within the NHS.

What we're watching

Regulatory Headwinds
The success of Imprivata’s offering hinges on its ability to navigate the evolving and increasingly stringent regulatory landscape within the UK healthcare sector, particularly the DSPT and Spine Authentication requirements.
Adoption Rate
The pace at which NHS Trusts and providers adopt the new passwordless authentication features will be a key indicator of Imprivata’s ability to reduce workflow friction and demonstrate tangible value to its clients.
Competitive Dynamics
How competitors respond to Imprivata’s enhanced EAM platform, particularly in offering similar CAF-aligned and Spine Authentication support, will determine the long-term market share and pricing pressures within the UK healthcare access management space.

Imprivata Bolsters Healthcare Security with Passwordless Access, Aims for Essential Eight Compliance

Event summary

  • Imprivata released new features for its Enterprise Access Management (EAM) platform on March 16, 2026.
  • The update includes context-aware passwordless authentication, high-assurance identity verification, and AI-powered behavioral analytics.
  • The new functionality is designed to help Australian healthcare organizations comply with the ACSC’s Essential Eight mitigation strategies.
  • Fran Rosch, CEO of Imprivata, emphasized the importance of fast, frictionless access for healthcare providers in the context of digital transformation.

The big picture

The Australian healthcare sector's accelerated digital transformation, coupled with increasing cyber threats, is driving demand for robust access management solutions. The Essential Eight framework, mandated by the ACSC, creates a clear regulatory pathway for vendors like Imprivata to demonstrate value and secure contracts. This move positions Imprivata to capitalize on the growing need for secure, efficient workflows within a highly regulated environment.

What we're watching

Regulatory Headwinds
The effectiveness of Imprivata’s Essential Eight alignment will depend on the ongoing interpretation and enforcement of ACSC guidelines, potentially creating compliance burdens for healthcare clients.
Adoption Rate
The pace at which Australian healthcare organizations adopt passwordless authentication will be influenced by clinician training and perceived security trade-offs, impacting Imprivata's revenue growth.
Competitive Landscape
How Imprivata differentiates its AI-powered behavioral analytics against competitors offering similar access management solutions will determine its market share gains within the Australian healthcare sector.

Imprivata Expands Access Management to Secure Healthcare's AI Agent Boom

Event summary

  • Imprivata introduced 'Agentic Identity Management' at HIMSS 2026 in Las Vegas.
  • The new platform secures and governs AI agents within healthcare environments.
  • Imprivata aims to address risks associated with AI agent manipulation, such as prompt injection attacks.
  • Agentic Identity Management treats AI agents as managed identities, enforcing least-privilege access and continuous monitoring.

The big picture

The healthcare sector is rapidly integrating AI agents to automate tasks and improve efficiency, creating a critical need for robust security and governance frameworks. Imprivata’s move to extend its identity management platform to encompass AI agents positions them to capitalize on this growing market, but also highlights the emerging complexity of securing increasingly autonomous systems within highly regulated environments. This represents a significant expansion beyond Imprivata’s traditional focus on human identity management.

What we're watching

Governance Dynamics
The adoption rate of Agentic Identity Management will depend on healthcare organizations' willingness to integrate AI governance into existing workflows, potentially facing resistance from clinicians accustomed to more autonomous processes.
Regulatory Headwinds
Increased scrutiny from regulatory bodies like HIPAA regarding AI-driven decision-making and data security could necessitate further feature development and compliance investments for Imprivata.
Execution Risk
Imprivata’s ability to integrate Agentic Identity Management across both modern and legacy healthcare systems will be crucial; failure to do so could limit adoption and impact revenue growth.

Imprivata Integrates Patient Access into Epic's MyChart, Expanding Biometric Verification

Event summary

  • Imprivata Patient Access is now available within Epic's Toolbox for MyChart, offering face recognition-based identity verification.
  • The integration supports IAL2 standards and aims to streamline patient account creation and management.
  • Imprivata Patient Access leverages existing patient photos within Epic to expedite check-in processes.
  • The solution is positioned to reduce misidentification, duplicate records, and claim denials within healthcare systems.
  • Imprivata's Dr. Sean Kelly highlighted the increasing pressure on healthcare organizations to balance digital access with security.

The big picture

The integration reflects the broader trend of healthcare providers seeking to enhance patient engagement and operational efficiency through digital solutions while grappling with stringent security and compliance requirements. Epic’s dominance in the EHR market makes this integration a significant distribution channel for Imprivata, but also exposes them to Epic’s evolving strategic priorities. The move aligns with CMS’s push to reduce administrative burdens and improve patient safety, potentially opening doors for broader adoption of biometric identification technologies across the healthcare system.

What we're watching

Adoption Rate
The success of this integration hinges on Epic clients adopting Imprivata Patient Access; slow uptake could limit the solution’s impact on Imprivata’s revenue growth.
Regulatory Scrutiny
Increased regulatory focus on biometric data privacy and security could necessitate further adjustments to Imprivata’s Patient Access offering and potentially impact adoption rates.
Competitive Landscape
The emergence of alternative patient identification solutions, particularly those integrated directly into competing EHR platforms, could erode Imprivata’s market share over time.

Imprivata Bolsters Access Management with Passwordless Push

Event summary

  • Imprivata released expanded capabilities for its Enterprise Access Management (EAM) platform on February 10, 2026.
  • The new EAM features include context-aware passwordless authentication, identity verification, and AI-powered risk signaling.
  • An Imprivata survey found that 85% of healthcare IT leaders consider passwordless authentication 'very important' or 'mission-critical', yet only 7% have fully adopted it.
  • The release highlights a challenge: 54% of organizations use at least three authentication vendors, indicating fragmentation in the access management space.

The big picture

Imprivata's move reflects the broader industry shift towards passwordless authentication driven by security concerns and the need for improved user experience. The company's focus on healthcare and mission-critical industries positions it to capitalize on the increasing regulatory pressure and operational demands for secure and efficient access management. However, the fragmented authentication vendor landscape presents a significant challenge to Imprivata's consolidation strategy.

What we're watching

Adoption Hurdles
The significant gap between perceived importance and actual adoption of passwordless authentication suggests Imprivata will need to demonstrate clear ROI and ease of integration to drive wider uptake within healthcare and other sectors.
Competitive Landscape
With 54% of organizations using multiple authentication vendors, Imprivata’s success hinges on its ability to consolidate functionality and displace existing solutions, rather than simply adding to the complexity.
Workflow Integration
The platform’s effectiveness will depend on seamless integration with existing workflows and systems, particularly legacy on-premises infrastructure, to avoid creating new bottlenecks for frontline workers.

Imprivata Secures Consecutive Best in KLAS Award, Signaling Healthcare Access Management Dominance

Event summary

  • Imprivata Enterprise Access Management (EAM) has been named the 2026 Best in KLAS for Access Management, marking the second consecutive year it has received the award.
  • The award is based on direct feedback from healthcare provider organizations, highlighting customer satisfaction and product performance.
  • Imprivata acquired Verosint, indicating a strategic focus on adaptive and risk-based access controls.
  • Customer testimonials emphasize the product's reliability, ease of configuration, and strong support services.
  • KLAS Research uses interviews with thousands of healthcare providers to determine the rankings.

The big picture

Imprivata's consecutive Best in KLAS awards underscore the critical role of secure access management in the healthcare sector, which is increasingly reliant on digital workflows and facing heightened cybersecurity threats. The acquisition of Verosint signals a strategic move towards more sophisticated security measures, reflecting a broader industry trend towards adaptive and risk-based access controls. The company's success is tied to the ongoing digital transformation of healthcare and the need for solutions that balance security, compliance, and operational efficiency.

What we're watching

Integration Risk
The successful integration of Verosint's technology and personnel will be crucial to realizing the planned innovations in adaptive and risk-based access, and any missteps could impact Imprivata's competitive advantage.
Competitive Landscape
While Imprivata holds the Best in KLAS award for two years running, the rapidly evolving access management landscape means competitors will likely accelerate innovation to challenge Imprivata's market position.
Customer Retention
Continued reliance on positive customer feedback, as evidenced by the KLAS awards and testimonials, suggests Imprivata’s ability to maintain its position hinges on sustaining high levels of customer satisfaction and loyalty.

Imprivata Backs CMS Initiative to Streamline Patient Record Access

Event summary

  • Imprivata has pledged support for the CMS Health Technology Ecosystem’s “Kill the Clipboard” initiative, aiming to simplify patient access to medical records.
  • The initiative seeks to reduce administrative burden for health systems by eliminating repetitive data entry for patients.
  • Imprivata’s ‘Patient Access’ solution verifies patient identity and authenticates access, reducing fraud and duplicate records.
  • Imprivata has also become a ‘Friend of the Ecosystem’ and committed to the CMS Interoperability Framework.
  • Dr. Sean Kelly, Chief Medical Officer at Imprivata, highlighted the frustration caused by patients repeatedly providing the same information.

The big picture

The CMS “Kill the Clipboard” initiative represents a broader push for patient-centric healthcare and data interoperability, driven by increasing regulatory pressure and consumer demand. Imprivata’s involvement signals a growing recognition within the access management sector that frictionless patient experiences are becoming a competitive necessity. This initiative, while laudable, faces the common challenge of integrating disparate systems within the fragmented US healthcare landscape.

What we're watching

Regulatory Headwinds
The success of Imprivata’s pledge is contingent on CMS’s ability to drive adoption of the Health Technology Ecosystem across diverse healthcare providers, which could face resistance due to existing legacy systems.
Execution Risk
Imprivata’s commitment to seamless data exchange requires tight integration with various CMS-aligned networks and personal health record applications, presenting significant technical and logistical challenges.
Governance Dynamics
The ‘Friend of the Ecosystem’ role will require Imprivata to navigate a complex web of stakeholders and potentially compromise on product development to align with broader CMS goals.

Healthcare Authentication Gap: 85% Demand Passwordless, Just 7% Adopt

Event summary

  • A new Imprivata survey found 85% of healthcare IT leaders consider passwordless authentication vital or mission-critical.
  • Only 7% of U.S. healthcare organizations have fully implemented passwordless access for clinical and non-clinical staff.
  • 60% of healthcare delivery organizations (HDOs) still heavily rely on passwords, leading to operational and security issues.
  • 23% of HDOs expect to fully adopt passwordless authentication within two years, a significant increase from the current rate.

The big picture

The survey highlights a critical disconnect between the recognized need for enhanced security and operational efficiency in healthcare and the slow pace of technological adoption. This gap represents a significant market opportunity for access management providers like Imprivata, but also underscores the inherent inertia within the highly regulated and risk-averse healthcare sector. The increasing frequency and sophistication of cyberattacks targeting healthcare organizations will likely accelerate the shift towards passwordless authentication, but overcoming integration, training, and compliance hurdles will be crucial for success.

What we're watching

Integration Hurdles
The 57% of HDOs citing integration and technical challenges as barriers suggest Imprivata's success hinges on simplifying implementation, potentially through strategic partnerships or acquisitions of complementary technology.
Clinical Adoption
The 52% concern about clinical acceptance and training indicates that Imprivata's go-to-market strategy must prioritize user experience and robust training programs to drive widespread adoption among clinicians.
Regulatory Impact
The 51% citing regulatory or compliance requirements as a barrier suggests that evolving healthcare data privacy regulations will increasingly dictate the timeline and scope of passwordless authentication deployments.
CID: 191